相关实验视频
Updated: Jul 8, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
自然化合物作为肥胖药物疗法
Xin-Yuan Zhao1, Ji-Qiu Wang2, G Gregory Neely3
1Laboratory of Metabolism and Aging, School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
天然化合物在治疗肥胖症方面表现有前途,但不同的研究设计使其使用变得复杂. 本综述总结了它们在动物模型中的有效性和机制,以指导未来的药物开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 肥胖影响全球超过9.88亿人,构成重大公共卫生挑战.
- 目前的肥胖药物治疗方法不足,引发了对天然化合物的兴趣.
- 30多年来,许多天然化合物已被研究为抗肥胖性质.
研究的目的:
- 在动物模型中系统地审查天然化合物的抗肥胖疗效.
- 阐明这些天然化合物的作用机制.
- 为从自然来源开发新型抗肥胖药物提供见解.
主要方法:
- 对自然化合物和肥胖的研究进行全面的文献搜索.
- 在动物模型中报告的抗肥胖作用的系统摘要.
- 分析实验设计的变化及其对报告疗效的影响.
主要成果:
- 在天然化合物中观察到抗肥胖疗效的显著差异.
- 动物模型,剂量,治疗持续时间和施用方法的差异影响了结果.
- 由于研究异质性,使用这些化合物作为药物治疗的可行性仍然不确定.
结论:
- 天然化合物为肥胖药物治疗提供了潜在的潜力.
- 标准化研究设计对于准确的疗效评估至关重要.
- 本综述强调了未来药物开发的有希望的天然化合物和机制.
更多相关视频
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
相关概念视频
Obesity
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Regulation of Food Intake
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...